NASDAQ drop outpaces biotech

In a reverse of Monday's session, in which the 6.2% decline in the BioCentury 100 Index was double that of the NASDAQ Composite, the NASDAQ on Tuesday slid 6.2%, while the BC100 fell 3.9%. The DJIA dr...